Pharmacy Barriers to Receiving Buprenorphine Among Patients Undergoing Telemedicine Addiction Treatment
Authors:
Open Access
- 1 August 2025
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 8 (8) , e2527418
Abstract
Importance: Buprenorphine is a first-line medication for opioid use disorder, yet many individuals face barriers to filling buprenorphine prescriptions. Telemedicine patients may have prescriptions questioned and rejected more frequently due to being perceived as a diversion risk due to their prescriber’s physical distance from the pharmacy.Objective: To evaluate pharmacy challenges in filling buprenorphine prescriptions among adults receiving telemedicine treatment for opioid use disorder overall and by rural and nonrural residence.Design, Setting, and Participants: This cross-sectional study analyzed a web-based survey conducted from August to September 2024. Adult patients receiving treatment from a telemedicine practice providing low-barrier treatment for opioid use disorder in 5 US states were included. Participants were identified through electronic health records; inclusion criteria were diagnosis of opioid use disorder, enrollment in telemedicine treatment with a valid zip code, and completion of a new evaluation visit and follow-up appointment.Exposure: Rural and nonrural residence determined by patient zip codes mapped to Rural-Urban Commuting Area codes.Main Outcomes and Measures: Self-reported frequency of buprenorphine fill problems in the past year, types of fill problems, and days without buprenorphine due to pharmacy-related challenges.Results: A total of 601 patients participated, with 300 (49.9%) residing in nonrural areas, 363 (60.4%) identifying as women, and a mean (SD) age of 41.44 (8.60) years. Nearly one-third of patients (192 [31.9%]) had to go without buprenorphine due to a pharmacy-related barrier in the past 12 months, and more than one-quarter (165 [27.5%]) reported having problems filling their buprenorphine prescription. There was no statistically significant difference in the experience of buprenorphine fill problems between rural and nonrural respondents. The most common problems were that buprenorphine was unavailable and needed ordering (90 of 165 [54.5%]), insurance coverage-related barriers (37 [22.4%]), and pharmacy hesitancy in filling a telemedicine prescription (32 [19.4%]).Conclusions and Relevance: In this cross-sectional study of patients receiving telemedicine treatment for opioid use disorder, challenges filling buprenorphine prescriptions were prevalent and led to concerning periods when patients were untreated and at an increased risk of returning to nonprescribed opioid use. There is a critical need for interventions to ensure sufficient access to buprenorphine, including implementing buprenorphine stocking requirements and medication delivery services through collaborating pharmacies.Keywords
This publication has 25 references indexed in Scilit:
- Availability of buprenorphine/naloxone films and naloxone nasal spray in community pharmacies in 11 U.S. statesDrug and Alcohol Dependence, 2022
- ‘Red Flags’ and ‘Red Tape’: Telehealth and pharmacy-level barriers to buprenorphine in the United StatesInternational Journal of Drug Policy, 2022
- Telehealth Adoption by Mental Health and Substance Use Disorder Treatment Facilities in the COVID-19 PandemicPsychiatric Services, 2022
- Ensuring buprenorphine access in rural community pharmacies to prevent overdosesJournal of the American Pharmacists Association, 2022
- Buprenorphine dispensing in an epicenter of the U.S. opioid epidemic: A case study of the rural risk environment in Appalachian KentuckyInternational Journal of Drug Policy, 2020
- Acute Care, Prescription Opioid Use, and Overdose Following Discontinuation of Long-Term Buprenorphine Treatment for Opioid Use DisorderAmerican Journal of Psychiatry, 2020
- What Is Rural? Challenges And Implications Of Definitions That Inadequately Encompass Rural People And PlacesHealth Affairs, 2019
- Pharmacists' readiness to provide naloxone in community pharmacies in West VirginiaJournal of the American Pharmacists Association, 2017
- Examination of the Link Between Medication Adherence and Use of Mail-Order Pharmacies in Chronic Disease StatesJournal of Managed Care & Specialty Pharmacy, 2016
- Discontinuation of Buprenorphine Maintenance Therapy: Perspectives and OutcomesJournal of Substance Abuse Treatment, 2015